216 related articles for article (PubMed ID: 23463912)
1. Use of a soluble epoxide hydrolase inhibitor as an adjunctive analgesic in a horse with laminitis.
Guedes AG; Morisseau C; Sole A; Soares JH; Ulu A; Dong H; Hammock BD
Vet Anaesth Analg; 2013 Jul; 40(4):440-8. PubMed ID: 23463912
[TBL] [Abstract][Full Text] [Related]
2. Soluble epoxide hydrolase activity and pharmacologic inhibition in horses with chronic severe laminitis.
Guedes A; Galuppo L; Hood D; Hwang SH; Morisseau C; Hammock BD
Equine Vet J; 2017 May; 49(3):345-351. PubMed ID: 27338788
[TBL] [Abstract][Full Text] [Related]
3. Anti-nociceptive efficacy of the soluble epoxide hydrolase inhibitor t-TUCB in horses with mechanically induced lameness.
Carlson A; Johnson PJ; Lei Z; Keegan KG
Res Vet Sci; 2022 Dec; 152():504-509. PubMed ID: 36174370
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and antinociceptive effects of the soluble epoxide hydrolase inhibitor t-TUCB in horses with experimentally induced radiocarpal synovitis.
Guedes AGP; Aristizabal F; Sole A; Adedeji A; Brosnan R; Knych H; Yang J; Hwang SH; Morisseau C; Hammock BD
J Vet Pharmacol Ther; 2018 Apr; 41(2):230-238. PubMed ID: 29067696
[TBL] [Abstract][Full Text] [Related]
5. Soluble Epoxide Hydrolase Inhibition by
Overby H; Yang Y; Xu X; Graham K; Hildreth K; Choi S; Wan D; Morisseau C; Zeldin DC; Hammock BD; Wang S; Bettaieb A; Zhao L
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32987880
[TBL] [Abstract][Full Text] [Related]
6. Soluble epoxide hydrolase inhibition is antinociceptive in a mouse model of diabetic neuropathy.
Wagner K; Yang J; Inceoglu B; Hammock BD
J Pain; 2014 Sep; 15(9):907-14. PubMed ID: 24924124
[TBL] [Abstract][Full Text] [Related]
7. Plasma concentrations, analgesic and physiological assessments in horses with chronic laminitis treated with two doses of oral tramadol.
Guedes A; Knych H; Hood D
Equine Vet J; 2016 Jul; 48(4):528-31. PubMed ID: 25832551
[TBL] [Abstract][Full Text] [Related]
8. Soluble epoxide hydrolase inhibitor, t-TUCB, protects against myocardial ischaemic injury in rats.
Shrestha A; Krishnamurthy PT; Thomas P; Hammock BD; Hwang SH
J Pharm Pharmacol; 2014 Sep; 66(9):1251-8. PubMed ID: 24697323
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of soluble epoxide hydrolase lowers portal hypertension in cirrhotic rats by ameliorating endothelial dysfunction and liver fibrosis.
Deng W; Zhu Y; Lin J; Zheng L; Zhang C; Luo M
Prostaglandins Other Lipid Mediat; 2017 Jul; 131():67-74. PubMed ID: 28822809
[TBL] [Abstract][Full Text] [Related]
10. Soluble epoxide hydrolase inhibition with t-TUCB alleviates liver fibrosis and portal pressure in carbon tetrachloride-induced cirrhosis in rats.
Zhang CH; Zheng L; Gui L; Lin JY; Zhu YM; Deng WS; Luo M
Clin Res Hepatol Gastroenterol; 2018 Apr; 42(2):118-125. PubMed ID: 29031875
[TBL] [Abstract][Full Text] [Related]
11. Effect of ketamine hydrochloride on the analgesic effects of tramadol hydrochloride in horses with signs of chronic laminitis-associated pain.
Guedes AG; Matthews NS; Hood DM
Am J Vet Res; 2012 May; 73(5):610-9. PubMed ID: 22533391
[TBL] [Abstract][Full Text] [Related]
12. Use of a soluble epoxide hydrolase inhibitor in smoke-induced chronic obstructive pulmonary disease.
Wang L; Yang J; Guo L; Uyeminami D; Dong H; Hammock BD; Pinkerton KE
Am J Respir Cell Mol Biol; 2012 May; 46(5):614-22. PubMed ID: 22180869
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors of soluble epoxide hydrolase minimize ischemia-reperfusion-induced cardiac damage in normal, hypertensive, and diabetic rats.
Islam O; Patil P; Goswami SK; Razdan R; Inamdar MN; Rizwan M; Mathew J; Inceoglu B; Stephen Lee KS; Hwang SH; Hammock BD
Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28296232
[TBL] [Abstract][Full Text] [Related]
14. Differential Effects of 17,18-EEQ and 19,20-EDP Combined with Soluble Epoxide Hydrolase Inhibitor
Yang Y; Xu X; Wu H; Yang J; Chen J; Morisseau C; Hammock BD; Bettaieb A; Zhao L
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34361032
[TBL] [Abstract][Full Text] [Related]
15. Identification and optimization of soluble epoxide hydrolase inhibitors with dual potency towards fatty acid amide hydrolase.
Kodani SD; Bhakta S; Hwang SH; Pakhomova S; Newcomer ME; Morisseau C; Hammock BD
Bioorg Med Chem Lett; 2018 Feb; 28(4):762-768. PubMed ID: 29366648
[TBL] [Abstract][Full Text] [Related]
16. Effects of ketoprofen and phenylbutazone on chronic hoof pain and lameness in the horse.
Owens JG; Kamerling SG; Stanton SR; Keowen ML
Equine Vet J; 1995 Jul; 27(4):296-300. PubMed ID: 8536666
[TBL] [Abstract][Full Text] [Related]
17. Acute equine laminitis: Exciting prospects afoot.
Bailey SR
Vet J; 2015 Nov; 206(2):121-2. PubMed ID: 26403957
[No Abstract] [Full Text] [Related]
18. Inhibition of soluble epoxide hydrolase attenuates eosinophil recruitment and food allergen-induced gastrointestinal inflammation.
Bastan I; Ge XN; Dileepan M; Greenberg YG; Guedes AG; Hwang SH; Hammock BD; Washabau RJ; Rao SP; Sriramarao P
J Leukoc Biol; 2018 Jul; 104(1):109-122. PubMed ID: 29345370
[TBL] [Abstract][Full Text] [Related]
19. The pharmacologic basis for the treatment of endocrinopathic laminitis.
Durham A
Vet Clin North Am Equine Pract; 2010 Aug; 26(2):303-14. PubMed ID: 20699177
[TBL] [Abstract][Full Text] [Related]
20. The pharmacologic basis for the treatment of developmental and acute laminitis.
Belknap JK
Vet Clin North Am Equine Pract; 2010 Apr; 26(1):115-24. PubMed ID: 20381740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
